Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153555 · ClinicalTrials.gov registry record
Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy
A clinical trial of Coronary Artery Disease, sponsored by Volcano Corporation.
- Completed
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT01153555 is a study of Coronary Artery Disease that has completed, run by Volcano Corporation. The registered enrollment target is 350 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01153555, a study of Coronary Artery Disease, has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-center, prospective registry of patients with intermediate coronary lesions defined as a stenosis of 40-80% by angiography. Approximately 300 patients will be enrolled into the study at sites in the United States and Europe. There will be no follow up beyond hospital discharge in this study. A sub-group of 30 patients will undergo Adenosine MRI. The investigators hypothesize that Intravascular Ultrasound Radiofrequency (IVUS RF) anatomical criteria, such as minimal luminal area, plaque burden and virtual histology plaque type, can predict physiological ischemia by Fractional Flow Reserve (FFR).
Conditions Studied
Study Locations (1)
District of Columbia
- Washingtoon Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01153555
The ClinicalTrials.gov registry entry for NCT01153555 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (73% lower). The listed sponsor is Volcano Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01153555 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01153555 about?
NCT01153555 is a clinical study titled "Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy". This is a multi-center, prospective registry of patients with intermediate coronary lesions defined as a stenosis of 40-80% by angiography. Approximately 300 patients will be enrolled into the study at sites in the United States and Europe. There will be no follow up beyond hospital discharge in thi...
What is the current status of trial NCT01153555?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2010-09. Estimated completion is 2012-06.
What conditions does trial NCT01153555 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
Who is sponsoring clinical trial NCT01153555?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01153555 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.